We hypothesized that galectin-3 and pentraxin-3 levels, along with inflammatory indices, would differ according to coronary artery disease severity and arrhythmia presence, reflecting their potential utility in risk stratification. This evidence concerns the gene LGALS3 and coronary artery disorder.